The relationship between serum uric acid concentration and metabolic syndrome in patients with schizophrenia or schizoaffective disorder

Chih Chiang Chiu, Chun Hsin Chen, Ming Chyi Huang, Po Yu Chen, Chang Jer Tsai, Mong Liang Lu

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Higher prevalence rates of metabolic syndrome (MetS) in patients with schizophrenia are getting more and more attention. Uric acid (UA) has been frequently reported to be associated with MetS in the general population. Sex difference in this relationship is inconsistent. As a selective antioxidant, UA has also been found to be reduced in patients with schizophrenia, and this effect may be prominent in men. With the inconsistent presentations, higher rate of MetS but possible lower UA concentrations, the aim of this study was to investigate the relationship by sexes between serum UA concentrations and prevalence of MetS in patients with schizophrenia or schizoaffective disorder. A total of 637 patients, 342 male and 295 female, were enrolled from 36 psychiatric rehabilitation institutions. Cross-sectional anthropometrical data, biochemical analysis, and serum UA were measured. Serum UA concentrations were divided into quartiles by sexes. Modified National Cholesterol Education Program Adult Treatment Panel III criteria for Asians were used as diagnosis of MetS. After adjustment, higher UA concentrations are associated with hypertriglyceridemia, low high-density lipoprotein cholesterol level, and high blood pressure in men and with hypertriglyceridemia in women. Significantly higher odds ratios for MetS in the UA third (4.02; 95% confidence interval, 1.33-12.1) and fourth quartiles (9.28; 95% confidence interval, 2.90-29.8) compared with the lowest quartile were found in men but not in women after adjustment. These results suggest that lower UA concentrations in male patients with schizophrenia or schizoaffective disorder are associated with lower risk of MetS.

Original languageEnglish
Pages (from-to)585-592
Number of pages8
JournalJournal of Clinical Psychopharmacology
Volume32
Issue number5
DOIs
Publication statusPublished - Oct 2012

Fingerprint

Uric Acid
Psychotic Disorders
Schizophrenia
Serum
Social Adjustment
Hypertriglyceridemia
Confidence Intervals
Sex Characteristics
LDL Cholesterol
HDL Cholesterol
Antioxidants
Odds Ratio
Cholesterol
Hypertension
Education
Population

Keywords

  • antipsychotics
  • hyperuricemia
  • metabolic syndrome
  • schizophrenia
  • uric acid

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Pharmacology (medical)

Cite this

The relationship between serum uric acid concentration and metabolic syndrome in patients with schizophrenia or schizoaffective disorder. / Chiu, Chih Chiang; Chen, Chun Hsin; Huang, Ming Chyi; Chen, Po Yu; Tsai, Chang Jer; Lu, Mong Liang.

In: Journal of Clinical Psychopharmacology, Vol. 32, No. 5, 10.2012, p. 585-592.

Research output: Contribution to journalArticle

@article{82a85df6c1e24ce2978480933ce7684d,
title = "The relationship between serum uric acid concentration and metabolic syndrome in patients with schizophrenia or schizoaffective disorder",
abstract = "Higher prevalence rates of metabolic syndrome (MetS) in patients with schizophrenia are getting more and more attention. Uric acid (UA) has been frequently reported to be associated with MetS in the general population. Sex difference in this relationship is inconsistent. As a selective antioxidant, UA has also been found to be reduced in patients with schizophrenia, and this effect may be prominent in men. With the inconsistent presentations, higher rate of MetS but possible lower UA concentrations, the aim of this study was to investigate the relationship by sexes between serum UA concentrations and prevalence of MetS in patients with schizophrenia or schizoaffective disorder. A total of 637 patients, 342 male and 295 female, were enrolled from 36 psychiatric rehabilitation institutions. Cross-sectional anthropometrical data, biochemical analysis, and serum UA were measured. Serum UA concentrations were divided into quartiles by sexes. Modified National Cholesterol Education Program Adult Treatment Panel III criteria for Asians were used as diagnosis of MetS. After adjustment, higher UA concentrations are associated with hypertriglyceridemia, low high-density lipoprotein cholesterol level, and high blood pressure in men and with hypertriglyceridemia in women. Significantly higher odds ratios for MetS in the UA third (4.02; 95{\%} confidence interval, 1.33-12.1) and fourth quartiles (9.28; 95{\%} confidence interval, 2.90-29.8) compared with the lowest quartile were found in men but not in women after adjustment. These results suggest that lower UA concentrations in male patients with schizophrenia or schizoaffective disorder are associated with lower risk of MetS.",
keywords = "antipsychotics, hyperuricemia, metabolic syndrome, schizophrenia, uric acid",
author = "Chiu, {Chih Chiang} and Chen, {Chun Hsin} and Huang, {Ming Chyi} and Chen, {Po Yu} and Tsai, {Chang Jer} and Lu, {Mong Liang}",
year = "2012",
month = "10",
doi = "10.1097/JCP.0b013e3182664e64",
language = "English",
volume = "32",
pages = "585--592",
journal = "Journal of Clinical Psychopharmacology",
issn = "0271-0749",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - The relationship between serum uric acid concentration and metabolic syndrome in patients with schizophrenia or schizoaffective disorder

AU - Chiu, Chih Chiang

AU - Chen, Chun Hsin

AU - Huang, Ming Chyi

AU - Chen, Po Yu

AU - Tsai, Chang Jer

AU - Lu, Mong Liang

PY - 2012/10

Y1 - 2012/10

N2 - Higher prevalence rates of metabolic syndrome (MetS) in patients with schizophrenia are getting more and more attention. Uric acid (UA) has been frequently reported to be associated with MetS in the general population. Sex difference in this relationship is inconsistent. As a selective antioxidant, UA has also been found to be reduced in patients with schizophrenia, and this effect may be prominent in men. With the inconsistent presentations, higher rate of MetS but possible lower UA concentrations, the aim of this study was to investigate the relationship by sexes between serum UA concentrations and prevalence of MetS in patients with schizophrenia or schizoaffective disorder. A total of 637 patients, 342 male and 295 female, were enrolled from 36 psychiatric rehabilitation institutions. Cross-sectional anthropometrical data, biochemical analysis, and serum UA were measured. Serum UA concentrations were divided into quartiles by sexes. Modified National Cholesterol Education Program Adult Treatment Panel III criteria for Asians were used as diagnosis of MetS. After adjustment, higher UA concentrations are associated with hypertriglyceridemia, low high-density lipoprotein cholesterol level, and high blood pressure in men and with hypertriglyceridemia in women. Significantly higher odds ratios for MetS in the UA third (4.02; 95% confidence interval, 1.33-12.1) and fourth quartiles (9.28; 95% confidence interval, 2.90-29.8) compared with the lowest quartile were found in men but not in women after adjustment. These results suggest that lower UA concentrations in male patients with schizophrenia or schizoaffective disorder are associated with lower risk of MetS.

AB - Higher prevalence rates of metabolic syndrome (MetS) in patients with schizophrenia are getting more and more attention. Uric acid (UA) has been frequently reported to be associated with MetS in the general population. Sex difference in this relationship is inconsistent. As a selective antioxidant, UA has also been found to be reduced in patients with schizophrenia, and this effect may be prominent in men. With the inconsistent presentations, higher rate of MetS but possible lower UA concentrations, the aim of this study was to investigate the relationship by sexes between serum UA concentrations and prevalence of MetS in patients with schizophrenia or schizoaffective disorder. A total of 637 patients, 342 male and 295 female, were enrolled from 36 psychiatric rehabilitation institutions. Cross-sectional anthropometrical data, biochemical analysis, and serum UA were measured. Serum UA concentrations were divided into quartiles by sexes. Modified National Cholesterol Education Program Adult Treatment Panel III criteria for Asians were used as diagnosis of MetS. After adjustment, higher UA concentrations are associated with hypertriglyceridemia, low high-density lipoprotein cholesterol level, and high blood pressure in men and with hypertriglyceridemia in women. Significantly higher odds ratios for MetS in the UA third (4.02; 95% confidence interval, 1.33-12.1) and fourth quartiles (9.28; 95% confidence interval, 2.90-29.8) compared with the lowest quartile were found in men but not in women after adjustment. These results suggest that lower UA concentrations in male patients with schizophrenia or schizoaffective disorder are associated with lower risk of MetS.

KW - antipsychotics

KW - hyperuricemia

KW - metabolic syndrome

KW - schizophrenia

KW - uric acid

UR - http://www.scopus.com/inward/record.url?scp=84865861621&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865861621&partnerID=8YFLogxK

U2 - 10.1097/JCP.0b013e3182664e64

DO - 10.1097/JCP.0b013e3182664e64

M3 - Article

C2 - 22926590

AN - SCOPUS:84865861621

VL - 32

SP - 585

EP - 592

JO - Journal of Clinical Psychopharmacology

JF - Journal of Clinical Psychopharmacology

SN - 0271-0749

IS - 5

ER -